INDEMNIFICATION AGREEMENTIndemnification Agreement • November 2nd, 2021 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 2nd, 2021 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is made as of this day of November, 2021 by and between La Jolla Pharmaceutical Company, a Delaware corporation (the “Company”) and (“Indemnitee”).
AGREEMENT AND PLAN OF MERGER OF LA JOLLA PHARMACEUTICAL COMPANY A DELAWARE CORPORATION, AND LA JOLLA PHARMACEUTICAL COMPANY, A CALIFORNIA CORPORATIONAgreement and Plan of Merger • November 2nd, 2021 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledNovember 2nd, 2021 Company IndustryThis AGREEMENT AND PLAN OF MERGER, effective as of November 2, 2021 (the “Merger Agreement”), is made by and between La Jolla Pharmaceutical Company, a Delaware corporation (“LJPC-Delaware”), and La Jolla Pharmaceutical Company, a California corporation (“LJPC-California”). LJPC-Delaware and LJPC-California are referred to herein as the “Constituent Corporations.” LJPC-Delaware is a wholly owned subsidiary of LJPC-California.